Tacrolimus dosing requirements in diabetic and nondiabetic patients calculated from pretransplantation data.

van Duijnhoven, E; Christiaans, M; Schäfer, A; Undre, N; van Hooff, J

van Duijnhoven, E; Christiaans, M; Schäfer, A; Undre, N; van Hooff, J.

Affiliation

van Duijnhoven E; Department of Internal Medicine, University Hospital Maastricht, The Netherlands.

Transplant Proc ; 30(4): 1266-7, 1998 Jun.

Article in En | MEDLINE | ID: mdl-9636514

Subject(s)

Diabetes Mellitus, Type 1/blood; Diabetic Nephropathies/surgery; Immunosuppressive Agents/pharmacokinetics; Immunosuppressive Agents/therapeutic use; Kidney Failure, Chronic/surgery; Kidney Transplantation/immunology; Tacrolimus/pharmacokinetics; Tacrolimus/therapeutic use; Adult; Dose-Response Relationship, Drug; Drug Monitoring; Humans; Immunosuppressive Agents/blood; Metabolic Clearance Rate; Middle Aged; Tacrolimus/blood

Search on Google

Add to My VHL

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Kidney Transplantation / Tacrolimus / Diabetes Mellitus, Type 1 / Diabetic Nephropathies / Immunosuppressive Agents / Kidney Failure, Chronic Limits: Adult / Humans / Middle aged Language: En Journal: Transplant Proc Year: 1998 Document type: Article Affiliation country: Netherlands Country of publication: United States

Search on Google

Add to My VHL

XML

PubMed Links